Divya Elsa Mathews

Hamad Medical Corporation

Papers

1

Total Citations

146

H-Index

1

About

Dr. Divya Elsa Mathews is a pioneering researcher at the intersection of nanorobotics, artificial intelligence, and neurotherapeutics. Her primary focus lies in engineering intelligent nanoscale systems capable of crossing the formidable blood-brain barrier (BBB)—a challenge that has long stymied conventional drug delivery for brain cancer and neurological disorders. In her landmark 2021 work, “Emerging Application of Nanorobotics and Artificial Intelligence To Cross the BBB,” which has garnered 146 citations, Dr. Mathews systematically deconstructs the BBB’s structural hierarchy and biochemical signaling, proposing AI-driven nanorobots that can dynamically maneuver and target the neurovascular unit with unprecedented precision. This contribution not only advances the design of smart theranostic agents but also lays a computational framework for real-time, controlled navigation within the brain’s microenvironment. Her research is widely recognized for bridging molecular engineering with machine learning, offering a transformative pathway for treating gliomas, Alzheimer’s, and other CNS pathologies. By integrating robotics, AI, and neuroscience, Dr. Mathews is shaping a future where minimally invasive, autonomous nanocarriers become a clinical reality—a vision that continues to inspire interdisciplinary innovation at the frontiers of nanomedicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
146
Total Citations
146
Avg Citations/Paper
🏆 Most Cited Paper
Emerging Application of Nanorobotics and Artificial Intelligence To Cross the BBB: Advances in Design, Controlled Maneuvering, and Targeting of the Barriers
146 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Hamad Medical Corporation

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago